Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis
Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study
Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Hundreds of Xarelto Bleeding Claims Already Pending in Federal MDL May 26, 2015 Irvin Jackson Add Your Comments Johnson & Johnson’s Janssen subsidiary and Bayer Healthcare face a rapidly growing number of product liability lawsuits filed on behalf of individuals nationwide who suffered severe and often fatal bleeding injuries on Xarelto. In December 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) established consolidated pretrial proceedings in the federal court system for all Xarelto bleeding claims, centralizing the cases before U.S. District Judge Eldon Fallon in the Eastern District of Louisiana, as part of a multidistrict litigation (MDL). At that time, there were only about two dozen complaints pending. According to the latest case list (PDF) released by the court last week, there are now 434 lawsuits pending before Judge Fallon, and the number is continuing to grow each month. Learn More About Xarelto Lawsuits Side Effects of Xarelto May Increase Risk of Uncontrollable Bleeding. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Xarelto Lawsuits Side Effects of Xarelto May Increase Risk of Uncontrollable Bleeding. Learn More SEE IF YOU QUALIFY FOR COMPENSATION As Xarelto injury lawyers continue to review and file claims, it is ultimately expected that several thousand lawsuits will be centralized before Judge Fallon to reduce duplicative discovery into common issues, avoid conflicting rulings from different judges and to serve the convenience of the parties, witnesses and the courts. A complaint (PDF) filed last week by Mary Lou Garza is one of the latest to join the litigation, containing similar allegations to those raised in many other claims. Garza indicates that her husband, Israel M. Garza, died of acute gastrointestinal bleeding in May 2013, only a few months after he began taking Xarelto. Israel Garza was switched to the new-generation anticoagulant after previously taking Coumadin (warfarin), which has been the go-to treatment for prevention of strokes among patients with atrial fibrillation for decades. Garza had no prior history of significant bleeding events or stroke, yet he began to experience dizziness caused by gastrointestinal bleeding two days after beginning Xarelto treatment. He suffered respiratory failure and acute anemia, ultimately leading to hospitalization for several months prior to his death. According to allegations raised in the Xarelto claim, Garza’s doctor would have never prescribed the drug had the manufacturers provided adequate warning about the bleeding risks or the lack of a safe and effective reversal agent that doctors could have used to stop or control bleeding events. “With the knowledge of the true relationship between use of Xarelto and irreversible bleeds, rather than taking steps to pull the drug off the market, provide strong warnings, or create an antidote, Defendants promoted and continue to promote Xarelto as a safe and effective treatment for AFib,” according to the Garza complaint. Xarelto Bleeding Risk Xarelto (rivaroxoaban) was introduced in 2011 as a superior replacement for Coumadin (warfarin), and has been aggressively marketed for patients suffering from atrial fibrillation or for prevention of blood clots following joint replacement surgery. As a result, the drug has quickly grown to become one of the top selling medications in the United States. While all blood thinners carry a risk of bleeding injury, Xarelto has been linked to a surprising number of problems as more and more patients are switched to the novel anticoagulant. Xarelto has been promoted as easier to use than warfarin, since it does not require regular blood monitoring. However, several recent studies have raised questions about those claims, with researchers suggesting that Xarelto blood monitoring may actually help doctors identify patients at the greatest risk of bleeding. In addition to failing to warn about the risk of bleeding and importance of blood monitoring, Garza and other plaintiffs pursuing bleeding claims against Bayer and Janssen allege that the drug makers withheld information about the lack of a Xarelto reversal agent, which doctors could use to stop hemorrhaging that may develop among users. While warfarin’s blooding thinning effects can be quickly reversed in an emergency, there is no antidote for Xarelto. Similar allegations were raised in the litigation over Pradaxa, which is another new-generation anticoagulant introduced by Boehringer Ingelheim in October 2010, one year before Xarelto hit the market. More than 4,000 Pradaxa lawsuits were filed by users of that drug who suffered bleeding injuries. Following several years of litigation, Boehringer Ingelheim ultimately agreed to pay $650 million in Pradaxa settlements, with an average of about $150,000 per claim. As part of the coordinated pretrial proceedings in the Xarelto litigation, Judge Fallon is expected to select a small group of claims to go through case-specific discovery and be prepared for a series of early trial dates. According to minutes (PDF) from a recent status conference before Judge Fallon, the parties are expected to propose a new case management order by the end of June, which will address selection of the bellwether claims and pretrial discovery. While the outcomes of any early trial dates will not be binding on other claims, they will heavily influence eventual Xarelto settlement negotiations to resolve the litigation. The next status conference in the Xarelto MDL is scheduled for June 10. Tags: Atrial Fibrillation, Bayer, Bleeding, Blood Thinners, Gastrointestinal Bleeding, Johnson & Johnson, Warfarin, Xarelto More Xarelto Lawsuit Stories Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis November 21, 2024 Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study September 1, 2022 Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study October 15, 2021 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Reports Highlight Sports Betting Addiction Problems Among Young Men (Posted: yesterday) Sports betting sites are fostering gambling addiction in young men nationwide, according to recent reports. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Alleges DraftKings Daily Fantasy Games Constitute Illegal Sports Gambling in California (06/05/2025)DraftKings Faces Lawsuit Over Failure To Pay Winning Bets (05/29/2025)Teen Gambling Problems Frequently Start With Online Sportsbook Betting: Study (05/16/2025) Tepezza Tinnitus and Hearing Loss Lawsuits Move Into Expert Discovery Phase (Posted: yesterday) Four Tepezza tinnitus and hearing loss lawsuits continue to be prepared for early trial dates next year, as plaintiffs’ lawyers submit case-specific expert reports this week. MORE ABOUT: TEPEZZA HEARING LOSS LAWSUITTepezza Lawyers Meet With MDL Judge To Review Status of Hearing Loss Lawsuits Today (03/31/2025)Bellwether Trials for Tepezza Hearing Damage Lawsuits Set To Begin in April, June, July and September 2026 (03/25/2025)Court Identifies 4 Tepezza Lawsuits Over Hearing Loss for Early Bellwether Trials (02/11/2025) Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (Posted: 2 days ago) The makers of the Depo-Provera birth control shot are asking the Pennsylvania court system to consolidate before one state judge all lawsuits over claims the injections caused brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Indicates Depo-Provera Meningioma Growth Risks Created Constant Distress (06/06/2025)Lawsuit Alleges Intracranial Meningioma From Depo-Provera Resulted in Need for Lifelong Medical Monitoring (05/28/2025)Depo-Provera Lawsuit Sign Ups Expected To Continue as First Brain Tumor Cases Prepared for Trial (05/23/2025)
Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis November 21, 2024
Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study September 1, 2022
Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study October 15, 2021
Reports Highlight Sports Betting Addiction Problems Among Young Men (Posted: yesterday) Sports betting sites are fostering gambling addiction in young men nationwide, according to recent reports. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Alleges DraftKings Daily Fantasy Games Constitute Illegal Sports Gambling in California (06/05/2025)DraftKings Faces Lawsuit Over Failure To Pay Winning Bets (05/29/2025)Teen Gambling Problems Frequently Start With Online Sportsbook Betting: Study (05/16/2025)
Tepezza Tinnitus and Hearing Loss Lawsuits Move Into Expert Discovery Phase (Posted: yesterday) Four Tepezza tinnitus and hearing loss lawsuits continue to be prepared for early trial dates next year, as plaintiffs’ lawyers submit case-specific expert reports this week. MORE ABOUT: TEPEZZA HEARING LOSS LAWSUITTepezza Lawyers Meet With MDL Judge To Review Status of Hearing Loss Lawsuits Today (03/31/2025)Bellwether Trials for Tepezza Hearing Damage Lawsuits Set To Begin in April, June, July and September 2026 (03/25/2025)Court Identifies 4 Tepezza Lawsuits Over Hearing Loss for Early Bellwether Trials (02/11/2025)
Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (Posted: 2 days ago) The makers of the Depo-Provera birth control shot are asking the Pennsylvania court system to consolidate before one state judge all lawsuits over claims the injections caused brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Indicates Depo-Provera Meningioma Growth Risks Created Constant Distress (06/06/2025)Lawsuit Alleges Intracranial Meningioma From Depo-Provera Resulted in Need for Lifelong Medical Monitoring (05/28/2025)Depo-Provera Lawsuit Sign Ups Expected To Continue as First Brain Tumor Cases Prepared for Trial (05/23/2025)